Live tape
Top 8, mentions 7d14,917HTZ3,801 mentions▲ +0.08SPCX2,913 mentions▲ +0.07GOOGL2,094 mentions▲ +0.03SNDK1,997 mentions▲ +0.08NVDA1,290 mentions▲ +0.08MSFT1,054 mentions▲ +0.06SPY948 mentions▲ +0.07VOO820 mentions▲ +0.08

Equity · Healthcare

PFE

Pfizer Inc. · NYSE

$26.64 +2.38% 1D Finazon · prior-day close
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for PFE to draw a line in its place.

The chart above plots the price of PFE over the range selected — one day to the full history — drawn by TradingView from their own data.

Market cap $151.8B
P/E (TTM) 17.1
52-week range $23.26 – $28.56
Avg volume 9.8M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 10, 2026

PFE insider trades

SEC Form 4

PFE has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 28 November 2025.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
28 Nov 2025 BOURLA ALBERT Chairman & CEO Award 23 $1K
14 Nov 2025 BOURLA ALBERT Chairman & CEO Award 24 $1K
31 Oct 2025 BOURLA ALBERT Chairman & CEO Award 24 $1K
15 Oct 2025 BOURLA ALBERT Chairman & CEO Award 25 $1K
14 Oct 2025 BOURLA ALBERT Chairman & CEO Award 83 $2K
30 Sep 2025 NARAYEN SHANTANU Award 1,962 $50K
30 Sep 2025 Taraporevala Cyrus Award 1,472 $38K
30 Sep 2025 Quincey James Award 1,521 $39K
30 Sep 2025 SMITH JAMES C Award 1,766 $45K
30 Sep 2025 Echevarria Joseph Award 1,815 $46K
30 Sep 2025 BOURLA ALBERT Chairman & CEO Award 24 $1K
15 Sep 2025 BOURLA ALBERT Chairman & CEO Award 25 $1K

Showing the 12 most recent of 17 compensation filings in this window. The figures above count all of them.

PFE reported financials

SEC EDGAR XBRL

PFE reported revenue of $62.6B for the fiscal year ended 31 Dec 2025. Net income over the same period was $7.8B.

Figure Reported Period
Revenue $62.6B 31 Dec 2025 fiscal year
Net income $7.8B 31 Dec 2025 fiscal year
Diluted EPS $1.36 31 Dec 2025 fiscal year
Total assets $201.1B 28 Jun 2026 at period end
Total equity $85.2B 28 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 28 Jun 2026

PFE earnings

SEC EDGAR
Date Period EPS Revenue
28 Jun 2026 Q2 2026 $-0.04 $15.03B
29 Mar 2026 Q1 2026 $0.47 $14.45B
31 Dec 2025 FY 2025 $1.36 $62.58B
28 Sep 2025 Q3 2025 $0.62 $16.65B
29 Jun 2025 Q2 2025 $0.51 $14.65B
30 Mar 2025 Q1 2025 $0.52 $13.72B
31 Dec 2024 FY 2024 $1.41 $63.63B
29 Sep 2024 Q3 2024 $0.78 $17.70B

Reported figures & scheduled dates · SEC EDGAR filings

PFE institutional holders

SEC Form 13F

1 of the 45 institutional funds we track reported a PFE position for the quarter ended 30 Jun 2026 — a combined $2.6B; the latest of those filings landed 04 Aug 2026.

Fund Action Shares Value
Fisher Asset Management Held (±25%) +3.9% shares 109,067,291 $2.6B

Source: SEC EDGAR 13F filings